Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
epilepsy
Biotech
Encoded lays off 29% of staff to fund Dravet gene therapy trial
Encoded is shrinking its headcount by 29% as the gene therapy biotech draws resources from its early-stage R&D toward its Dravet syndrome program.
James Waldron
Feb 13, 2025 10:20am
Takeda axes epilepsy asset after FDA weighs in on data package
Jan 30, 2025 7:19am
Atalanta loads crossbow with $97M, 2 Big Pharmas in tow
Jan 28, 2025 7:00am
Gene therapy reduces seizures in mice with severe epilepsy
Dec 9, 2024 11:46am
FDA places Rapport's nerve damage trial on hold
Nov 7, 2024 8:50am
Angelini pens $360M biobucks pact for ph. 1 brain disorder drug
Oct 21, 2024 10:04am